Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas
- PMID: 17689286
- DOI: 10.1016/j.oraloncology.2007.04.004
Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas
Abstract
Two mechanisms of radiotherapy resistance of major importance in head and neck cancer are tumour cell repopulation and hypoxia. Hypoxic tumour cells that retain their clonogenic potential can survive radiation treatment and lead to local recurrences. The aim of this study was to quantify this cellular population in a cohort of human head and neck carcinomas and to investigate the prognostic significance. The proliferation marker iododeoxyuridine (IdUrd) and the hypoxia marker pimonidazole were administered intravenously prior to biopsy taking in patients with stage II-IV squamous cell carcinoma of the head and neck. Triple immunohistochemical staining of blood vessels, IdUrd and pimonidazole was performed and co-localization of IdUrd and pimonidazole was quantitatively assessed by computerized image analysis. The results were related with treatment outcome. Thirty-nine biopsies were analyzed. Tumours exhibited different patterns of proliferation and hypoxia but generally the IdUrd signal was found in proximity to blood vessels whereas pimonidazole binding was predominantly at a distance from vessels. Overall, no correlations were found between proliferative activity and oxygenation status. The fraction of IdUrd-labelled cells positive for pimonidazole ranged from 0% to 16.7% with a mean of 2.4% indicating that proliferative activity was low in hypoxic areas and occurring mainly in the well-oxygenated tumour compartments. IdUrd positive cells in hypoxic areas made up only 0.09% of the total viable tumour cell mass. There were no associations between the magnitude of this cell population and local tumour control or survival. Co-localization between proliferating cells and hypoxia in head and neck carcinomas was quantified using an immunohistochemical triple staining technique combined with a computerized simultaneous analysis of multiple parameters. The proportion of cells proliferating under hypoxic conditions was small and no correlation with treatment outcome could be found.
Similar articles
-
Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas.Radiother Oncol. 2005 Aug;76(2):213-8. doi: 10.1016/j.radonc.2005.06.030. Radiother Oncol. 2005. PMID: 16112214
-
Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1.Anticancer Res. 2005 Mar-Apr;25(2A):1015-21. Anticancer Res. 2005. PMID: 15868941
-
The fate of hypoxic (pimonidazole-labelled) cells in human cervix tumours undergoing chemo-radiotherapy.Radiother Oncol. 2006 Aug;80(2):138-42. doi: 10.1016/j.radonc.2006.07.022. Epub 2006 Aug 17. Radiother Oncol. 2006. PMID: 16916562 Clinical Trial.
-
Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.Head Neck. 2007 Jun;29(6):591-604. doi: 10.1002/hed.20543. Head Neck. 2007. PMID: 17252597 Review.
-
Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.Ear Nose Throat J. 2008 Nov;87(11):634-43. Ear Nose Throat J. 2008. PMID: 19006065 Review.
Cited by
-
Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models.Mol Oncol. 2024 Aug;18(8):1885-1903. doi: 10.1002/1878-0261.13620. Epub 2024 Mar 1. Mol Oncol. 2024. PMID: 38426642 Free PMC article.
-
Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response.Phys Med Biol. 2013 Jul 21;58(14):4897-919. doi: 10.1088/0031-9155/58/14/4897. Epub 2013 Jun 21. Phys Med Biol. 2013. PMID: 23787766 Free PMC article.
-
The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study.Transl Oncol. 2010 Jun 1;3(3):160-9. doi: 10.1593/tlo.09265. Transl Oncol. 2010. PMID: 20563257 Free PMC article.
-
Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.Oncotarget. 2017 Feb 21;8(8):12983-13002. doi: 10.18632/oncotarget.14677. Oncotarget. 2017. PMID: 28099905 Free PMC article.
-
Evaluation of the Combined Effect of 2ME2 and (60)Co on the Inducement of DNA Damage by IUdR in a Spheroid Model of the U87MG Glioblastoma Cancer Cell Line Using Alkaline Comet Assay.Cell J. 2011 Summer;13(2):83-90. Epub 2011 Aug 24. Cell J. 2011. PMID: 23508289 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical